Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genelux (GNLX) Liabilities and Shareholders Equity (2022 - 2025)

Genelux has reported Liabilities and Shareholders Equity over the past 4 years, most recently at $19.0 million for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $19.0 million for Q4 2025, down 45.19% from a year ago — trailing twelve months through Dec 2025 was $76.3 million (down 47.35% YoY), and the annual figure for FY2025 was $19.0 million, down 45.19%.
  • Liabilities and Shareholders Equity for Q4 2025 was $19.0 million at Genelux, down from $25.0 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for GNLX hit a ceiling of $45.2 million in Q2 2024 and a floor of $5.5 million in Q4 2022.
  • Median Liabilities and Shareholders Equity over the past 4 years was $30.1 million (2023), compared with a mean of $28.9 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 404.3% in 2023 and later tumbled 45.19% in 2025.
  • Genelux's Liabilities and Shareholders Equity stood at $5.5 million in 2022, then surged by 404.3% to $27.9 million in 2023, then rose by 24.46% to $34.7 million in 2024, then plummeted by 45.19% to $19.0 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $19.0 million (Q4 2025), $25.0 million (Q3 2025), and $32.2 million (Q2 2025) per Business Quant data.